Thursday, 22 January 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 22 January 2026
News

Pharma's most valuable brand

Posted 19 January 2026 AM

Johnson & Johnson has been named the most valuable brand in pharma for the seventh year in a row, with Eli Lilly moving up three spots to number two, and Roche slipping to third.

The rankings were calculated by brand valuation consultancy Brand Finance, and published in the Brand Finance Healthcare 2025 report last year. The figures represent the net economic benefit that a brand owner would achieve by licensing their brand in the open market.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (13)

Access & Reimbursement (1)

Clinical & Medical, R&D (4)

Regulatory, Pharmacovigilance & QA (5)

Other (11)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.